EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 90 pce

7680686920026 CH-68692 C10BA06 07.12.0.

Reimbursement limitations:

EZET_ROS_SAN

EZETIMIB ROSUVASTATIN SANDOZ est indiqué comme traitement substitutif chez le patient adulte qui reçoit déjà …

EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 90 pce
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 90 pce
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 90 pce
1 / 3
google

Details

Product number
6869201
CPT
-
Packaging group
90
Unit
mg
Composition
ezetimibum 10 mg, rosuvastatinum 5.0 mg ut rosuvastatinum calcicum, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum K 29-32, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 4000, E 172 (flavum), talcum, E 172 (rubrum), pro compresso obducto corresp. natrium 1.669 mg.

Articles (1)

Ezetimib Rosuvastatin Sandoz 10 mg / 5 mg, Filmtabletten
Filmtabletten
90
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/02/2025
Patient information leaflet
Français
11/02/2025
Patient information leaflet
Italien
11/02/2025
Professional SmPC
Allemand
11/02/2025
Professional SmPC
Français
11/02/2025
Professional SmPC
Italien
11/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
200.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
1.669 MG Substance HBESI

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
68692
Drug name
Ezetimib Rosuvastatin Sandoz, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
03/02/2023
Authorization expiration date
02/02/2028
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 90 pce
Description (DE)
EZETIMIB ROSUVA Sandoz Filmtabl 10 mg/5 mg 90 Stk
Market launch
03/02/2023
Narcotic (BTM)
No

Other packaging sizes

EZETIMIB ROSUVA Sandoz cpr pell 10 mg/5 mg 30 pce
30 MG
GTIN: 7680686920019
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/10 mg 30 pce
30 MG
GTIN: 7680686920033
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/10 mg 90 pce
90 MG
GTIN: 7680686920040
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 30 pce
30 MG
GTIN: 7680686920057
View
EZETIMIB ROSUVA Sandoz cpr pell 10 mg/20 mg 90 pce
90 MG
GTIN: 7680686920064
View